These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35885050)

  • 1. Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease.
    Gutierrez BA; Limon A
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease.
    Ding Y; Zhao J; Zhang X; Wang S; Viola KL; Chow FE; Zhang Y; Lippa C; Klein WL; Gong Y
    Front Neurol; 2019; 10():1140. PubMed ID: 31736856
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
    Compta Y; Revesz T
    J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.
    Overk CR; Masliah E
    Biochem Pharmacol; 2014 Apr; 88(4):508-16. PubMed ID: 24462903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synapse as a treatment avenue for Alzheimer's Disease.
    Peng L; Bestard-Lorigados I; Song W
    Mol Psychiatry; 2022 Jul; 27(7):2940-2949. PubMed ID: 35444256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).
    Mroczko B; Groblewska M; Litman-Zawadzka A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.
    Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G
    J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease.
    Perdigão C; Barata MA; Araújo MN; Mirfakhar FS; Castanheira J; Guimas Almeida C
    Front Cell Neurosci; 2020; 14():72. PubMed ID: 32362813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease.
    Yin X; Qiu Y; Zhao C; Zhou Z; Bao J; Qian W
    Med Sci Monit; 2021 Sep; 27():e933084. PubMed ID: 34471085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Oligomers Neurotoxicity.
    Niewiadomska G; Niewiadomski W; Steczkowska M; Gasiorowska A
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33418848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.